Q3 FY2026 · ended Sep 30, 2026 · Revenue $335.56M, -0.7% YoY · Filed Oct 28, 2026
Conmed Corporation (CNMD) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $335.6 million and net income of $19.8 million. Free cash flow was $46.7 million. As of Sep 30, 2026 it held $48.0 million in cash and investments and $635.8 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- CNMD (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Largo, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 816956
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $335.6M | $343.5M | $373.2M | $337.9M | $342.3M |
| Operating income | $37.1M | $36.4M | $36.6M | $11.9M | $38.2M |
| Net income | $19.8M | $23.1M | $16.7M | $2.9M | $21.4M |
| Diluted EPS | $0.66 | $0.77 | $0.54 | $0.09 | $0.69 |
| Operating cash flow | $49.4M | $50.6M | $46.3M | $53.7M | $29.1M |
| Free cash flow | $46.7M | $44.7M | $41.2M | $48.5M | $23.4M |
| Total assets | $2.3B | $2.3B | $2.3B | $2.3B | $2.3B |
| Total liabilities | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
| Stockholders' equity | $1.1B | $1.0B | $1.0B | $1.0B | $1.0B |
| Cash and investments | $48.0M | $37.3M | $40.8M | $38.9M | $33.9M |
| Total debt | $635.8M | $657.0M | $886.8M | $853.0M | $881.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2026 | Oct 28, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Material agreement
|
Jun 4, 2026 | Jun 3, 2026 |
All 1000 Conmed Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.